Mesenchymal stem cells (MSCs) are non-haematopoietic cells which can be easily isolated from bone marrow and other tissues, such as adipose, umbilical cord, and peripheral blood.
ANTI AGING therapies
CRISPR/Cas9 in Treating Monogenic Disorders: A Breakthrough in Sickle Cell Anemia Therapy
CRISPR/Cas9, a revolutionary gene-editing technology, offers new hope for treating monogenic disorders like sickle cell anemia. By precisely targeting and correcting the mutated gene responsible for the disease, CRISPR/Cas9 has the potential to provide a permanent cure, offering significant implications for patients and healthcare systems.
